Literature DB >> 30554116

Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.

Asghar Fallah1, Ali Sadeghinia2, Houman Kahroba3, Amin Samadi4, Hamid Reza Heidari5, Behzad Bradaran6, Sirous Zeinali7, Ommoleila Molavi8.   

Abstract

Angiogenesis is a critical step in the progression of almost all human malignancies and some other life-threatening diseases. Anti-angiogenic therapy is a novel and effective approach for treatment of angiogenesis-dependent diseases such as cancer, diabetic retinopathy, and age-related macular degeneration. In this article, we will review the main strategies developed for anti-angiogenic therapies beside their clinical applications, the major challenges, and the latest advances in the development of anti-angiogenesis-based targeted therapies.
Copyright © 2018 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Angiogenesis-dependent diseases; Anti-angiogenesis; Anti-angiogenic therapeutics; Cancer; VEGF–VEGFR system receptors

Mesh：

Substances：

Year:  2018        PMID： 30554116     DOI： 10.1016/j.biopha.2018.12.022

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN： 0753-3322            Impact factor:   6.529


  44 in total

Review 1.  Exosomes: from carcinogenesis and metastasis to diagnosis and treatment of gastric cancer.

Authors:  Houman Kahroba; Mohammad Saeid Hejazi; Nasser Samadi
Journal:  Cell Mol Life Sci       Date:  2019-02-08       Impact factor: 9.261

Review 2.  Lactate: More Than Merely a Metabolic Waste Product in the Inner Retina.

Authors:  Rupali Vohra; Miriam Kolko
Journal:  Mol Neurobiol       Date:  2020-01-08       Impact factor: 5.590

3.  Advances in 3D Vascularized Tumor-on-a-Chip Technology.

Authors:  Sangmin Jung; Hyeonsu Jo; Sujin Hyung; Noo Li Jeon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 4.  Microfluidics in vascular biology research: a critical review for engineers, biologists, and clinicians.

Authors:  Grigor Simitian; María Virumbrales-Muñoz; Cristina Sánchez-de-Diego; David J Beebe; David Kosoff
Journal:  Lab Chip       Date:  2022-09-27       Impact factor: 7.517

5.  Enantioselective Synthesis of Homoisoflavanones by Asymmetric Transfer Hydrogenation and Their Biological Evaluation for Antiangiogenic Activity.

Authors:  Myunghoe Heo; Bit Lee; Kamakshi Sishtla; Xiang Fei; Sanha Lee; Soojun Park; Yue Yuan; Seul Lee; Sangil Kwon; Jungeun Lee; Sanghee Kim; Timothy W Corson; Seung-Yong Seo
Journal:  J Org Chem       Date:  2019-08-05       Impact factor: 4.354

6.  Dysregulated KDR and FLT1 Gene Expression in Colorectal Cancer Patients.

Authors:  Fatemeh Mohammad Rezaei; Shahryar Hashemzadeh; Reyhaneh Ravanbakhsh Gavgani; Mohammadali Hosseinpour Feizi; Nasser Pouladi; Hossein Samadi Kafil; Leila Rostamizadeh; Vahid Kholghi Oskooei; Mohammad Taheri; Ebrahim Sakhinia
Journal:  Rep Biochem Mol Biol       Date:  2019-10

7.  In Ovo and In Silico Evaluation of the Anti-Angiogenic Potential of Syringin.

Authors:  Charlaine A Aventurado; Junie B Billones; Ross D Vasquez; Agnes L Castillo
Journal:  Drug Des Devel Ther       Date:  2020-11-25       Impact factor: 4.162

Review 8.  Circular RNAs in Hepatocellular Carcinoma: Emerging Functions to Clinical Significances.

Authors:  Yucheng Zhang; Yali Wang
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

9.  Loss of endothelial glucocorticoid receptor promotes angiogenesis via upregulation of Wnt/β-catenin pathway.

Authors:  Bing Liu; Han Zhou; Tiening Zhang; Xixiang Gao; Bo Tao; Hao Xing; Zhenwu Zhuang; Alan Dardik; Themis R Kyriakides; Julie E Goodwin
Journal:  Angiogenesis       Date:  2021-03-02       Impact factor: 10.658

Review 10.  Cell type-specific microRNA therapies for myocardial infarction.

Authors:  Bohao Liu; Bryan Wang; Xiaokan Zhang; Roberta Lock; Trevor Nash; Gordana Vunjak-Novakovic
Journal:  Sci Transl Med       Date:  2021-02-10       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.